PiepoliMFHoesAWAgewallSet al.European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur J Prev Cardiol2016; 23: NP1–NP96.
2.
Vinther JL, Jacobsen RK and Jorgensen T. Current European Guidelines for management of cardiovascular disease: Is medical treatment in nearly half a population realistic? Eur J Prev Cardiol 2018; 25: 157–163.
3.
GubelmannCVollenweiderPMarques-VidalP. Association of grip strength with cardiovascular risk markers. Eur J Prev Cardiol2017; 24: 514–521.
4.
Lazzeroni D, Bini M, Camaiora U, et al. Serum uric acid level predicts adverse outcomes after myocardial revascularization or cardiac valve surgery. Eur J Prev Cardiol 2018; 25: 119–126.
5.
TolstrupJSWium-AndersenMKOrstedDDet al.Alcohol consumption and risk of atrial fibrillation: Observational and genetic estimates of association. Eur J Prev Cardiol2016; 23: 1514–1523.
6.
DuDBrunoRDwyerTet al.Associations between alcohol consumption and cardio-metabolic risk factors in young adults. Eur J Prev Cardiol2017; 24: 1967–1978.
7.
GorenekBPellicciaABenjaminEJet al.European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). Eur J Prev Cardiol2017; 24: 4–40.
8.
Persson CE, Adiels M, Björck L, et al. Young women, body size and risk of atrial fibrillation. Eur J Prev Cardiol 2018; 25: 173–180.
9.
KotsevaKWoodDDe BacquerDet al.EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol2016; 23: 636–648.
10.
Eindhoven DC, Hilt AD, Zwaan TC, et al. Age and gender differences in medical adherence after myocardial infarction: Women do not receive optimal treatment – The Netherlands claims database. Eur J Prev Cardiol 2018; 25: 181–189.
11.
RadtkeTPoerschkeDWilhelmMet al.Acute effects of Finnish sauna and cold-water immersion on haemodynamic variables and autonomic nervous system activity in patients with heart failure. Eur J Prev Cardiol2016; 23: 593–601.
12.
Lee E, Laukkanen T, Kunutsor SK, et al. Sauna exposure leads to improved arterial compliance: Findings from a non-randomised experimental study. Eur J Prev Cardiol 2018; 25: 130–138.
13.
Schmid JP. Some like it hot: Cardiovascular health benefits of Finnish sauna. Eur J Prev Cardiol 2018; 25: 127–129.
14.
ChuPGotinkRAYehGYet al.The effectiveness of yoga in modifying risk factors for cardiovascular disease and metabolic syndrome: A systematic review and metaanalysis of randomized controlled trials. Eur J Prev Cardiol2016; 23: 291–307.
15.
Lachman S, Boekholdt SM, Luben RN, et al. Impact of physical activity on the risk of cardiovascular disease in middle-aged and older adults: EPIC Norfolk prospective population study. Eur J Prev Cardiol 2018; 25: 200–208.
16.
HuangGWangRChenPet al.Dose–response relationship of cardiorespiratory fitness adaptation to controlled endurance training in sedentary older adults. Eur J Prev Cardiol2016; 23: 518–529.
17.
Kamiya K, Hamazaki N, Matsue Y, et al. Gait speed has comparable prognostic capability to six-minute walk distance in older patients with cardiovascular disease. Eur J Prev Cardiol 2018; 25: 212–219.
18.
EichlerSSalzwedelAReibisRet al.Multicomponent cardiac rehabilitation in patients after transcatheter aortic valve implantation: Predictors of functional and psychocognitive recovery. Eur J Prev Cardiol2017; 24: 257–264.
19.
De SmedtDClaysEHoferSet al.Validity and reliability of the HeartQoL questionnaire in a large sample of stable coronary patients: The EUROASPIRE IV Study of the European Society of Cardiology. Eur J Prev Cardiol2016; 23: 714–721.
20.
Zangger G, Zwisler AD, Kikkenborg Berg S, et al. Psychometric properties of HeartQoL, a core heart disease-specific health-related quality of life questionnaire, in Danish implantable cardioverter defibrillator recipients. Eur J Prev Cardiol 2018; 25: 142–149.